期刊文献+

肾病综合征患者尿足细胞与临床病理关系的分析 被引量:6

Relationship between urinary podocyte and clinicopathological features in patients with nephrotic syndrome
下载PDF
导出
摘要 目的通过观察肾病综合征(NS)患者尿足细胞与临床病理关系,探讨尿足细胞检测代替肾活检的可能性。方法选取80例NS患者被肾穿前1 d的晨尿和20例正常对照的晨尿各100 ml,离心涂片。用抗人足细胞标记蛋白Podocalyxin(PCX)单克隆抗体分别对尿沉渣涂片和肾组织切片进行免疫组化及免疫荧光检测,并于光学显微镜下计数尿足细胞数目及肾小球足细胞密度,比较NS各种类型尿足细胞排泄情况与肾脏临床病理的相关性;同时收集患者的临床一般资料和实验室资料,并分析其与尿足细胞和肾组织足细胞的关系。结果各组间年龄、性别构成及临床生化指标比较差异均无统计学意义(P>0.05)。正常对照组免疫组化及免疫荧光检测尿未见足细胞,免疫组化及免疫荧光检测肾组织PCX,可见大量足细胞;NS不同类型组与正常对照组尿足细胞及肾小球足细胞密度相比有统计学差异(P>0.05);各类型组中,以局灶节段性肾小球硬化(FSGS)组患者尿中检出的足细胞数最多,其次是系膜增生性肾小球肾炎(MsPGN)组,再次是膜性肾病(MN)、微小病变性肾病(MCD)。各组患者尿足细胞数与24 h尿蛋白量及肾小球病理积分呈正相关(P<0.05),与血浆白蛋白、肾小球肾足细胞密度呈负相关(P<0.05),与血肌酐无相关性(P>0.05);各组患者肾小球足细胞密度与24 h尿蛋白量及尿足细胞呈负相关(P<0.05),与血浆白蛋白及肾小球病理积分呈正相关(P<0.05),与血肌酐无相关(P>0.05)。结论尿足细胞的检测是一项可反映肾病综合征不同病理类型病情轻重的无创性指标;尿足细胞数有可能作为反应肾脏病变进展的重要指标。 Objective To explore the possibility of urinary podocyte test instead of renal biopsy by observing the relationship between urinary podoeyte and clinical pathological features in patients with nephrotic syndrome(NS). Methods The morning urine of 100 ml was collected from 80 NS patients before the renal biopsy and 20 healthy controls. The anti-human PCX monoclonal antibody was used to detect the number of urinary podocyte and the density of glomerular podocytes by immunofluorescence and immunohistocbemistry under the microscope. The correlation of urinary podocyte with clinical pathology of kidney was analyzed in NS patients. The general clinical data and laboratory data of patients ware collected, and their relationships with urinary podocyte and glomerular podocytes were analyzed. Results There was no statistically significant difference in age, gender and biochemical indices among different NS groups (P 〉 0.05 ). No podocytes were found in urine of healthy controls, but a lot of podocytes were detected in kidney tissues. There was statistically significant difference in the number of urinary podocytes and the density of glomerular podocytes between nephrotie syndrome group and healthy con-trol group, and the number of urinary podocyte was the most in patients with focal segmental glomerulosclerosis( FSGS), followed by me-sangial proliferative glomerulonephritis( MsPGN), membranous nephropathy(MN) ,and minimal change disease(MCD). The number of u-rinary podocyte in NS group was positively correlated with 24 h urinary protein quantity and glomerular pathological scores ( P 〈 0. 05 ), negatively correlated with serum albumin and glomerular PCX expression quantity (P 〈 0.05 ), but was not correlated with serum creatinine ( P 〉 0.05 ). The number of glomerular PCX in NS group was negatively correlated with 24 h urinary protein quantity and urinary podocyte ( P 〈 0.05 ), positively correlated with serum albumin and glomerular pathological scores ( P 〈0.05 ), but not to serum creatinine ( P 〉 0. 05 ). Conclusion The urinary podocyte is a non-invasive indicator to diagnose different path ological types of the nephrotic syndrome, and the number of urinary podocytes could be an important indicator to reflect the progress of kidney disease.
出处 《山西医科大学学报》 CAS 2013年第12期926-930,1005,1006,共7页 Journal of Shanxi Medical University
关键词 肾病综合征 足细胞 病理学 nephrotic syndrome podoeyte pathology
  • 相关文献

参考文献20

  • 1Asanuma K, Mndel P. The role of podocytes in glomerula pathobi- ology [ J ]. Clin Exp Nephrol,2003 ,7 :255 - 259.
  • 2Zhu Lei, Jiang Ruihua, Aoudjit L, et al, Activation of RhoA in podocytes induces focal segmental glomerulosclerosis [ J ]. J Am Soc Nephro1,2011,22 : 1621 - 1630.
  • 3邹万忠.肾活检病理诊断标准指导意见[J].中华肾脏病杂志,2001,17(4):270-274. 被引量:381
  • 4Lemley KV, Lafayette RA, Safai M, et al. Podoeytepenia and dis- ease severity in IgA nephropathy [ J ]. Kidney Int, 2002, 61 : 1475 - 1485.
  • 5Braden GL, Mulhern JG, O' Shea MH, et al. Changing inci- dence of glomerular diseases in adults [ J ]. Am J Kidney Dis, 2000,35:878 - 883.
  • 6Troyanov S, Wall CA, Miller JA, et al. Focal and segmental glo- merulosclerosis: Definition and relevance of a partial remission [J]. J Am Sac Nephrol, 2005,16:1061 - 1068.
  • 7Antignae C. Genetic models:Clues for understanding the patho-genesis of idiopathic nephrotic syndrome [ J ]. J Clin Invest; 2002,109:447 - 449.
  • 8Wiggins RC. The spectrum of podocytopathies : A unifying view of glomerular diseases[ J]. Kidney Int, 2007,71 : 1205 - 1214.
  • 9Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis:Diphtheria toxin-induced podocyte de- pletion in rats expressing human diphtheria toxin receptor trans- gene[ J]. J Am Soc Nephrol, 2005,16:2941 - 2952.
  • 10Kretzler M. Role of podocytes in focal sclrosis : Defining the point of no return[J]. J Am Soc Nephrol, 2005,16:2830 -2832.

二级参考文献39

  • 1杨念生,武庆庆,姜宗培,张锐,王芳,罗明乾,关伟明,余学清,叶任高.维甲酸抑制大鼠单侧输尿管梗阻模型肾间质纤维化[J].中华肾脏病杂志,2004,20(3):194-198. 被引量:19
  • 2周伟,陈楠,潘晓霞,陈晓农,任红,王朝辉,巫永睿,陆颖.局灶节段性肾小球硬化与NPHS2基因突变[J].肾脏病与透析肾移植杂志,2005,14(2):126-130. 被引量:10
  • 3李惊子,黄海长,刘颖,鄂杰.检测尿足细胞在活动性肾小球疾病中的意义[J].北京大学学报(医学版),2005,37(5):463-466. 被引量:34
  • 4石岩,丁洁.家族性局灶节段性肾小球硬化3家系临床表型与相关基因连锁分析[J].中国循证儿科杂志,2006,1(3):177-186. 被引量:11
  • 5Camici M. Urinary detection of podocyte injury. Biomed Pharmacother, 2007,61 (5) : 245 - 249.
  • 6Hara M, Yanagihara T, Takada T, et al. Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol, 1998,18( 1 ) : 35 - 41.
  • 7Hara M, Yanagihara T, Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron, 2001,89 (3) : 342 - 347.
  • 8Barroso S, Martinez JM, Martin MV, et al. Accuracy of indirect estimates of renal function in advanced chronic renal failure patients. Nefrologia, 2006,26 (3) : 344 - 350.
  • 9Vogelmann SU, Nelson W J, Myers BD, et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol, 2003,285 ( 1 ) : F40 - F48.
  • 10Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renalallograft rejection by measurement of messenger RNA for per forin and granzyme B in urine. N Engl J Med,2001,344(13) 947 - 954.

共引文献420

同被引文献40

  • 1孙虹云.糖尿病肾病血小板数量与体积变化的临床观察[J].安徽医药,2005,9(3):195-196. 被引量:1
  • 2Mcgarry JD. Dysregulation of fatty acid metabolism in the etiology ottype 2 Diabetes. Diabetes,2002,51:7-18.
  • 3Abdollahi M, Farshchi A, Nikfars E, et al. Effect of chromium on glucose and lipid profiles in patients with type 2 didbetes;a metaanalysis review of ran domized trials. J pham pharm Sci,2013,16:99-114.
  • 4Zhu L,Jiang R,Aoudjit L,et al. Activation of RhoA in podocy tes indues focal segmental glomerulosclerosis. J Am Soc Nephrol, 2011,22 : 1621 - 1630.
  • 5Lai WL, Yeh TH, Chen PM, et al. Membranous nephropathy: Areview on the pathogenesis, diagnosis, and treatment[ J]. J Formos Med Assoc,2015,114(2) :102 -111.
  • 6Lemley KV, Lafayette RA, Safai M, et al. Podocytepenia and disease severity in IgA nephropathy[ J]. Kidney Int,2002,61:1475 -1485.
  • 7范亚平,达展云,李大勇,等.膜性肾病肾活检组织中podoca-lyxin、TRPC6表达改变及其意义[C].中华医学会肾脏病学分会2010学术年会论文集,2010:220-220.
  • 8Chen Y, Schieppati A, Chen X, et al. lmmunosuppressive treat- ment for idiopathic membranous nephropathy in adults with ne- phmtie syndrome [ J]. Cochrane Database Syst Rev, 2014, 10: CD004293.
  • 9Chen WC, Chen SY, Chen CH, et al. Lack of association be- tween transient receptor potential cation channel 6 polymorphisms and primary membranous omerulonephritis [ J ]. Ren Fail, 2010,32(6) :666 -672.
  • 10Kavoura E, Gakiopoulou H, Paraskevakou H, et al. Immunohis- tochemieal evaluation of podocalyxin expression in glomerulopa- thies associated with nephrotie syndrome[J]. Hum Patho1,2011 , 42(2) :227 -235.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部